Copyright Reports & Markets. All rights reserved.

Global Gynaecological Cancer Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Gynaecological Cancer Drugs Market Overview

      • 1.1 Product Overview and Scope of Gynaecological Cancer Drugs
      • 1.2 Gynaecological Cancer Drugs Segment By Drug Class
        • 1.2.1 Global Gynaecological Cancer Drugs Production Growth Rate Comparison By Drug Class (2014-2025)
        • 1.2.2 Alkylating Agent
        • 1.2.3 Plant Alkaloid
        • 1.2.4 Anthracyclines
        • 1.2.5 Antitumor Antibiotic
        • 1.2.6 Others
      • 1.3 Gynaecological Cancer Drugs Segment by Application
        • 1.3.1 Gynaecological Cancer Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital Pharmacies
        • 1.3.3 Retail Pharmacies
        • 1.3.4 E-commerce
      • 1.4 Global Gynaecological Cancer Drugs Market by Region
        • 1.4.1 Global Gynaecological Cancer Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Gynaecological Cancer Drugs Market Size
        • 1.5.1 Global Gynaecological Cancer Drugs Revenue (2014-2025)
        • 1.5.2 Global Gynaecological Cancer Drugs Production (2014-2025)

      2 Global Gynaecological Cancer Drugs Market Competition by Manufacturers

      • 2.1 Global Gynaecological Cancer Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Gynaecological Cancer Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Gynaecological Cancer Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Gynaecological Cancer Drugs Production Sites, Area Served, Product Types
      • 2.5 Gynaecological Cancer Drugs Market Competitive Situation and Trends
        • 2.5.1 Gynaecological Cancer Drugs Market Concentration Rate
        • 2.5.2 Gynaecological Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Gynaecological Cancer Drugs Production Market Share by Regions

      • 3.1 Global Gynaecological Cancer Drugs Production Market Share by Regions
      • 3.2 Global Gynaecological Cancer Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Gynaecological Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Gynaecological Cancer Drugs Production
        • 3.4.1 North America Gynaecological Cancer Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Gynaecological Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Gynaecological Cancer Drugs Production
        • 3.5.1 Europe Gynaecological Cancer Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Gynaecological Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Gynaecological Cancer Drugs Production (2014-2019)
        • 3.6.1 China Gynaecological Cancer Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Gynaecological Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Gynaecological Cancer Drugs Production (2014-2019)
        • 3.7.1 Japan Gynaecological Cancer Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Gynaecological Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Gynaecological Cancer Drugs Consumption by Regions

      • 4.1 Global Gynaecological Cancer Drugs Consumption by Regions
      • 4.2 North America Gynaecological Cancer Drugs Consumption (2014-2019)
      • 4.3 Europe Gynaecological Cancer Drugs Consumption (2014-2019)
      • 4.4 China Gynaecological Cancer Drugs Consumption (2014-2019)
      • 4.5 Japan Gynaecological Cancer Drugs Consumption (2014-2019)

      5 Global Gynaecological Cancer Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Gynaecological Cancer Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Gynaecological Cancer Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Gynaecological Cancer Drugs Price by Type (2014-2019)
      • 5.4 Global Gynaecological Cancer Drugs Production Growth by Type (2014-2019)

      6 Global Gynaecological Cancer Drugs Market Analysis by Applications

      • 6.1 Global Gynaecological Cancer Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Gynaecological Cancer Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Gynaecological Cancer Drugs Business

      • 7.1 Roche Holdings
        • 7.1.1 Roche Holdings Gynaecological Cancer Drugs Production Sites and Area Served
        • 7.1.2 Gynaecological Cancer Drugs Product Introduction, Application and Specification
        • 7.1.3 Roche Holdings Gynaecological Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 AstraZeneca
        • 7.2.1 AstraZeneca Gynaecological Cancer Drugs Production Sites and Area Served
        • 7.2.2 Gynaecological Cancer Drugs Product Introduction, Application and Specification
        • 7.2.3 AstraZeneca Gynaecological Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Sanofi
        • 7.3.1 Sanofi Gynaecological Cancer Drugs Production Sites and Area Served
        • 7.3.2 Gynaecological Cancer Drugs Product Introduction, Application and Specification
        • 7.3.3 Sanofi Gynaecological Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Eli Lilly
        • 7.4.1 Eli Lilly Gynaecological Cancer Drugs Production Sites and Area Served
        • 7.4.2 Gynaecological Cancer Drugs Product Introduction, Application and Specification
        • 7.4.3 Eli Lilly Gynaecological Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Pfizer
        • 7.5.1 Pfizer Gynaecological Cancer Drugs Production Sites and Area Served
        • 7.5.2 Gynaecological Cancer Drugs Product Introduction, Application and Specification
        • 7.5.3 Pfizer Gynaecological Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Takeda Pharmaceuticals
        • 7.6.1 Takeda Pharmaceuticals Gynaecological Cancer Drugs Production Sites and Area Served
        • 7.6.2 Gynaecological Cancer Drugs Product Introduction, Application and Specification
        • 7.6.3 Takeda Pharmaceuticals Gynaecological Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Bristol-Myers Squibb
        • 7.7.1 Bristol-Myers Squibb Gynaecological Cancer Drugs Production Sites and Area Served
        • 7.7.2 Gynaecological Cancer Drugs Product Introduction, Application and Specification
        • 7.7.3 Bristol-Myers Squibb Gynaecological Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Merck
        • 7.8.1 Merck Gynaecological Cancer Drugs Production Sites and Area Served
        • 7.8.2 Gynaecological Cancer Drugs Product Introduction, Application and Specification
        • 7.8.3 Merck Gynaecological Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Dr Reddy’s Laboratories
        • 7.9.1 Dr Reddy’s Laboratories Gynaecological Cancer Drugs Production Sites and Area Served
        • 7.9.2 Gynaecological Cancer Drugs Product Introduction, Application and Specification
        • 7.9.3 Dr Reddy’s Laboratories Gynaecological Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Johnson & Johnson
        • 7.10.1 Johnson & Johnson Gynaecological Cancer Drugs Production Sites and Area Served
        • 7.10.2 Gynaecological Cancer Drugs Product Introduction, Application and Specification
        • 7.10.3 Johnson & Johnson Gynaecological Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 GlaxoSmithKline
      • 7.12 Apotex
      • 7.13 Hoffmann-La Roche
      • 7.14 Novartis
      • 7.15 Pfizer
      • 7.16 Teva Pharmaceutical

      8 Gynaecological Cancer Drugs Manufacturing Cost Analysis

      • 8.1 Gynaecological Cancer Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Gynaecological Cancer Drugs
      • 8.4 Gynaecological Cancer Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Gynaecological Cancer Drugs Distributors List
      • 9.3 Gynaecological Cancer Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Gynaecological Cancer Drugs Market Forecast

      • 11.1 Global Gynaecological Cancer Drugs Production, Revenue Forecast
        • 11.1.1 Global Gynaecological Cancer Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Gynaecological Cancer Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Gynaecological Cancer Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Gynaecological Cancer Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Gynaecological Cancer Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Gynaecological Cancer Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Gynaecological Cancer Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Gynaecological Cancer Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Gynaecological Cancer Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Gynaecological Cancer Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Gynaecological Cancer Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Gynaecological Cancer Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Gynaecological Cancer Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Gynaecological Cancer Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Gynaecological Cancer Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Gynaecological cancers are being diagnosed among women on a large scale and are also emerging as one of the leading causes of death in various regions.
        The surge of innovation in gynaecological cancer treatments is attracting all the major participants in the market for cancer drugs. Scientific advances are leading to the new treatment options in the market. Hence, the gynaecological cancer drugs market is also expected to see a significant growth in the coming years.
        Increasing investment by government and the private sector in hospitals and presence of specialist surgeons is also resulting in increased number of patients, thereby leading to the increased use of gynaecological cancer drugs.
        Rise in focus of vendors on emerging markets, such as Asia-Pacific and LAMEA, is expected to boost the market growth. Currently, multinational companies are focusing on investing in the GCC region as well as Latin America and Africa to expand their global reach and gain a competitive advantage.

        The global Gynaecological Cancer Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Gynaecological Cancer Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gynaecological Cancer Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Roche Holdings
        AstraZeneca
        Sanofi
        Eli Lilly
        Pfizer
        Takeda Pharmaceuticals
        Bristol-Myers Squibb
        Merck
        Dr Reddy’s Laboratories
        Johnson & Johnson
        GlaxoSmithKline
        Apotex
        Hoffmann-La Roche
        Novartis
        Pfizer
        Teva Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        By Drug Class
        Alkylating Agent
        Plant Alkaloid
        Anthracyclines
        Antitumor Antibiotic
        Others
        By Indication
        Cervical Cancer
        Uterine Cancer
        Ovarian & Fallopian Tube Cancer
        Vulvar Cancer
        Vaginal Cancer

        Segment by Application
        Hospital Pharmacies
        Retail Pharmacies
        E-commerce

        Buy now